EPPENDORF SE

Company Snapshot

Founded: 1945
Entity Type: Private
Employees: 4,658
Region: Americas
Revenue: $1,060.9 Millions
Revenue Year: 2024
Headquarter: Hamburg, Germany
Key Geographics: Americas, Europe, Asia-Pacific, Africa, China
Corporate Address: Barkhausenweg 1 22339 Hamburg Germany Tel: +49-40-53-801-0 www.eppendorf.com

Company Overview

Eppendorf SE manufactures, develops, and markets premium products, software, and services for use in global research and industrial labs. With its headquarters located in Hamburg, Germany, the company currently has production and research facilities across Europe, Asia, and North America.

Eppendorf serves the following sectors: consumables, lab solutions, bioprocess, separation and instrumentation, and liquid handling. Its product line includes centrifuges, mixers, dispensers, pipettes and pipetting robots. The company also sells shakers, fermenters, bioreactors, incubators for CO2, and ultra-low temperature freezers. Microplates, reaction tubes, pipette tips, and single-use bioreactors are examples of consumables that complete the line of premium, top-notch items.

Financial Highlights (FY 2024)

Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***

This information is available for BCC Research members only.

EPPENDORF SE In Reports

Separation Systems for Commercial Biotechnology

According to BCC Research detailed report on Separation Systems for Commercial Biotechnology market report includes global revenue ($ million) for base year data 2024, estimated data for 2025, and forecast data for 2026...

Bioprocess Optimization and Digital Bio-manufacturing: Global Markets

BCC Research Market Analyst says global market for bioprocess optimization and digital biomanufacturing is expected to grow from $24.3 billion in 2024 and is projected to reach $39.6 billion by the end of 2029

Single-use Technologies for Biopharmaceuticals: Global Markets

BCC Research Market Analyst says global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029 at a CAGR of...

Company's Business Segments

  • Separation and Instrumentation : Centrifuges, Ultra-low-temperature (ULT) freezers, PCR thermal cyclers
  • Liquid Handling : Pipettes and pipetting aids, Pipette manager (connected pipettes), Automated pipetting systems
  • Consumables : Sample tubes, Pipette tips, Multiwell plates
  • Lab Solutions (Bioprocess and Digital) : Bioreactors, Bioprocess control systems, Bioprocess Autosampler

Applications/End User Industries

  • Biotechnology
  • Pharmaceuticals
  • Clinical Diagnostics
  • Academic Research
  • Environmental Testing
  • Food and Beverage
AI Sentiment